Evaluating the application and limitations of bio-based solvents within organic synthesis
1 of 25
The development of small molecule inhibitors for fibrosis drug discovery
2 of 25
Expedient access to C-aryl linked saturated heterocyclic motifs
3 of 25
The design and synthesis of molecular tools for probing biological function
4 of 25
The development of novel organocatalytic and transition-metal catalysed methodologies for amide bond formation
5 of 25
New methods for the construction of selectively difluorinated carbocycles
6 of 25
Approaches to lead generation for idiopathic pulmonary fibrosis targets
7 of 25
Investigations into the generation and pleiotropic reactivity modes of the nitrile imine 1,3-dipole
8 of 25
Development of novel allosteric regulators of proteinase-activated receptors
9 of 25
The development of natural products as phytotoxic leads for herbicide discovery
10 of 25
Investigation of LPA₁ receptor antagonism / ATX inhibition by a scaffold hopping aproach and SAR analysis
11 of 25
The synthesis and optimisation of toll-like receptor agonists as potential immunomodulatory agents
12 of 25
Structure-guided approaches to the design of novel autotaxin inhibitors
13 of 25
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
14 of 25
Studies towards the synthesis and labelling of bioactive peptides
15 of 25
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
16 of 25
The design, synthesis and optimisation of calcium release-activated calcium (CRAC) channel inhibitors and mitochondrial permeability transition pore (mPTP) modulators, using phenotypic screening